Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacomicrobiomics informs clinical pharmacogenomics.
Katsila T, Balasopoulou A, Tsagaraki I, Patrinos GP. Katsila T, et al. Among authors: patrinos gp. Pharmacogenomics. 2019 Jul;20(10):731-739. doi: 10.2217/pgs-2019-0027. Epub 2019 Aug 1. Pharmacogenomics. 2019. PMID: 31368841
Genetic databases and their potential in pharmacogenomics.
Lagoumintzis G, Poulas K, Patrinos GP. Lagoumintzis G, et al. Among authors: patrinos gp. Curr Pharm Des. 2010;16(20):2224-31. doi: 10.2174/138161210791792804. Curr Pharm Des. 2010. PMID: 20459387 Review.
Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.
Georgitsi M, Viennas E, Gkantouna V, Christodoulopoulou E, Zagoriti Z, Tafrali C, Ntellos F, Giannakopoulou O, Boulakou A, Vlahopoulou P, Kyriacou E, Tsaknakis J, Tsakalidis A, Poulas K, Tzimas G, Patrinos GP. Georgitsi M, et al. Among authors: patrinos gp. Pharmacogenomics. 2011 Jan;12(1):49-58. doi: 10.2217/pgs.10.169. Pharmacogenomics. 2011. PMID: 21174622
Transcriptional regulation and pharmacogenomics.
Georgitsi M, Zukic B, Pavlovic S, Patrinos GP. Georgitsi M, et al. Among authors: patrinos gp. Pharmacogenomics. 2011 May;12(5):655-73. doi: 10.2217/pgs.10.215. Pharmacogenomics. 2011. PMID: 21619428 Review.
Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy.
Tafrali C, Paizi A, Borg J, Radmilovic M, Bartsakoulia M, Giannopoulou E, Giannakopoulou O, Stojiljkovic-Petrovic M, Zukic B, Poulas K, Stavrou EF, Lambropoulou P, Kourakli A, Felice AE, Papachatzopoulou A, Philipsen S, Pavlovic S, Georgitsi M, Patrinos GP. Tafrali C, et al. Among authors: patrinos gp. Pharmacogenomics. 2013 Apr;14(5):469-83. doi: 10.2217/pgs.13.31. Pharmacogenomics. 2013. PMID: 23556445
334 results